期刊文献+

左心房三维结构对老年心房颤动导管射频消融术后影响的研究 被引量:8

Effect of left atrial 3-dimensional structure on senile atrial fibrillation after catheter radiofrequency ablation
下载PDF
导出
摘要 目的 探讨左心房三维结构与心房颤动(房颤)类型以及导管射频消融术后房颤复发的相关性.方法 采用回顾性研究方法,选取接受房颤导管射频消融治疗的115例患者,分为阵发性房颤组75例、持续性房颤组25例和长期持续性房颤组15例;另选择同期入院的无房颤患者25例作为对照组.术前采用64层螺旋CT扫描,测量左心房容积(LAV)和左心房前容积(LA-Ant)/LAV比值,并进行术后随访.结果 与对照组比较,阵发性房颤组LAV、左心耳、LA-Ant、左心房后容积(LA-post)和LA-Ant/LAV比值明显升高(P〈0.05);与阵发性房颤组比较,持续性房颤组LAV、LA-Ant、LA-post明显升高(P〈0.05);多变量分析显示,LAV(OR=0.965,95%CI:0.937~0.983,P=0.014)和LA-Ant/LAV比值(OR=0.885,95%CI:0.821~0.989,P=0.013)为房颤复发的预测指标.结论 老年性房颤患者,LAV和左心房的不对称是房颤导管射频消融术后复发的预测因素.阵发性房颤、持续性房颤和长期持续性房颤具有左心房逐渐不规则扩张的趋势. Objective To study the correlation of left atrial (LA) 3-dimensional structure with atrial fibrillation(AF) and its recurrence after catheter radiofrequency ablation. Methods One hundred and fifteen AF patients after catheter radiofrequency ablation were divided into paroxysmal AF group (n = 75), persistent AF group (n = 25), and permanent AF group (n = 15). Twenty-five non-AF subjects served as a control group. Their left atrial volume (LAV) and LA-Ant/LAV ratio were measured by 64-slice spiral CT scanning. The patients were followed up after operation. Results The LAV,LAA and LA-Ant were significantly higher in paroxysmal AF group than in control group (P〈0.05). The LAV,LA-Ant and LA-post were significantly higher in persistent AF group than in paroxysmal AF group (P〈0.05). The LAV (OR=0. 965,95% CI. 0. 937- 0. 983,P=0. 014) and the LA-Ant/LAV ratio (OR=0. 885,95;CI.0. 821--0. 989,P=0. 013) were the predictors for the recurrence of AF. Conclusion LAV and left atrial asymmetry are the predicators for the recurrence of AF in senile AF patients after catheter radiofrequency ablation. Paroxysmal,persistent and permanent AF tend to irregularly enlarge the left atrium.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2013年第9期899-902,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 心房功能 心房颤动 导管消融术 肺静脉 华法林 复发 早期诊断 atrial function, left atrial fibrillation catheter ablation pulmonary veins warfarin recurrence early diagnosis
  • 相关文献

参考文献15

  • 1Fuster V, Ryd6n LE,Cannom DS, et al. 20tl ACCF/AHA/ HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fi- brillation a report of the American College of Cardiology Foundation/American Heart Association Task Force on prac- tice guidelines. Circulation, 2011,123 .. e269-e367.
  • 2brillation. J Mol Cell Cardiol, 2010,48 : 461-467.
  • 3Lehto M, Jurkko R, Parikka H,et al. Reversal of atrial re- modeling of ter cardioversion of persistent atrial fibrillation measured with magnetocardiography. Pacing Clin Electro physiol, 2009,32 : 217-223.
  • 4Camm AJ,Kirehhof P,Lip GY,et al. Guidelines for the man- agement of atrial fibrillation: the task force for the manage- ment of atrial fibrillation of the European Society of Cardiolo gy (ESC). Eur Heart J,2010,31:2369-2429.
  • 5张善春,吴卫平,王振福,张熙,孙虹,王婷,陈海波,管锦群.206例老年心房颤动患者抗栓治疗及血管事件发生情况5年随访[J].中华老年心脑血管病杂志,2012,14(5):497-499. 被引量:11
  • 6Wokhlu A, Hodge DO, Monahan KH,et al. Long term out come of atrial fibrillation ablation: impact and predictors of very late recurrence. J Cardiovasc Electrophysiol, 2010, 21: 1071-1078.
  • 7Themistoclakis S, Sehweikert RA, Saliba Wl, et al. Clinical predictors and relationship between early and late atrial tach- yarrhythmias of ter pulmonary vein antrum isolation. Heart Rhythm, 2008,5 : 679-685.
  • 8Hoffmeister PS,Chaudhry GM, Mendel J, et ah Evaluation of left atrial and posterior mediastinal anatomy by multidetector helical computed tomography imaging: relevance to ablation. J Intervent Cardiac Electrophysiol, 2007,18 : 217-223.
  • 9Iwasaki YK, Nishida K, Kato T, et al. Atrial fibrillation pathophysiology: implications for management. Circulation, 2011,124 : 2264-2274.
  • 10Nakamura K,Funabashi N, Uehara M, et al. Left atrial wall thickness in paroxysmal atrial fibrillation by multislice-CT is initial marker of structural remodeling and predictor of transi- tion from paroxysmal to chronic form. Int J Cardiot, 2009, 148:139-147.

二级参考文献8

  • 1Lakshminarayan K, Solid CA, Collins AJ, et al. Atrial fibrilla- tion and stroke in the general medicare population: A 10-year perspective(1992 to 2002). Stroke,2006,37: 1969 1974.
  • 2Hopps S, Marcy TR. Warfarin versus aspirin using CHADS2 to guide therapy for stroke prevention in nonva[vular atrial fibrillation. Consult Pharm, 2009,24,841 844.
  • 3Connolly S, Yusuf S, Budaj A, et al. Rationale and design of ACTIVE:The atrial fibrillation clopidogrel trial with irbesar- tan for prevention of vascular events. Am Heart J, 2006,151 : 1187-1193.
  • 4Diener HC, Saeco RL, Yusuf S, et al. Prevention Regimen for Effectively Avoiding Second Strokes(PRoFESS) study group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemie stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PROFESS) trial: A double-blind, active and placebo-controlled study. Lancet Neurol,2008,7:875 884.
  • 5Bhatt DL, Fox KA, Hacke W, et al. CHARISMA Investiga- tors. Clopidogrel and aspirin versus aspirin alone for the pre vention of atherothrombotic events. N Engl J Med, 2006,354 : 1706- 1717.
  • 6Lai KC, Chu KM, Hui WM, et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. Clin Gastroenterol Hepatol, 2006,4: 860- 865.
  • 7Ho PM,Maddox TM,Wang L,et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA, 2009,301 : 937-944.
  • 8中国卒中一级预防指南2010[J].中华神经科杂志,2011,44(4):282-288. 被引量:167

共引文献10

同被引文献50

引证文献8

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部